-
1
-
-
22244449596
-
High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses
-
Abd El-Rehim D.M., Ball G., Pinder S.E., Rakha E., Paish C., Robertson J.F.R., Macmillan D., Blamey R.W., Ellis I.O. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int. J. Cancer 2005, 116:340-350.
-
(2005)
Int. J. Cancer
, vol.116
, pp. 340-350
-
-
Abd El-Rehim, D.M.1
Ball, G.2
Pinder, S.E.3
Rakha, E.4
Paish, C.5
Robertson, J.F.R.6
Macmillan, D.7
Blamey, R.W.8
Ellis, I.O.9
-
2
-
-
70450203033
-
Mixtools: an R package for analyzing finite mixture models
-
Benaglia T., Chauveau D., Hunter D.R., Young D.S. Mixtools: an R package for analyzing finite mixture models. J.Stat. Softw. 2009, 32:1-29.
-
(2009)
J.Stat. Softw.
, vol.32
, pp. 1-29
-
-
Benaglia, T.1
Chauveau, D.2
Hunter, D.R.3
Young, D.S.4
-
3
-
-
0028875410
-
Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
-
Bergh J., Norberg T., Sjögren S., Lindgren A., Holmberg L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat. Med. 1995, 1:1029-1034.
-
(1995)
Nat. Med.
, vol.1
, pp. 1029-1034
-
-
Bergh, J.1
Norberg, T.2
Sjögren, S.3
Lindgren, A.4
Holmberg, L.5
-
4
-
-
84899487317
-
Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients
-
Bertucci F., Finetti P., Roche H., Doussal J.M.L., Marisa L., Martin A.L., Lacroix-Triki M., Blanc-Fournier C., Jacquemier J., Peyro-Saint-Paul H., Viens P., Sotiriou C., Birnbaum D., Penault-Llorca F. Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients. Ann. Oncol. 2012.
-
(2012)
Ann. Oncol.
-
-
Bertucci, F.1
Finetti, P.2
Roche, H.3
Doussal, J.M.L.4
Marisa, L.5
Martin, A.L.6
Lacroix-Triki, M.7
Blanc-Fournier, C.8
Jacquemier, J.9
Peyro-Saint-Paul, H.10
Viens, P.11
Sotiriou, C.12
Birnbaum, D.13
Penault-Llorca, F.14
-
5
-
-
33745948105
-
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients
-
Calza S., Hall P., Auer G., Bjöhle J., Klaar S., Kronenwett U., Liu E.T., Miller L., Ploner A., Smeds J., Bergh J., Pawitan Y. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res. 2006, 8:R34.
-
(2006)
Breast Cancer Res.
, vol.8
-
-
Calza, S.1
Hall, P.2
Auer, G.3
Bjöhle, J.4
Klaar, S.5
Kronenwett, U.6
Liu, E.T.7
Miller, L.8
Ploner, A.9
Smeds, J.10
Bergh, J.11
Pawitan, Y.12
-
6
-
-
0042125511
-
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
-
Chang J.C., Wooten E.C., Tsimelzon A., Hilsenbeck S.G., Gutierrez M.C., Elledge R., Mohsin S., Osborne C.K., Chamness G.C., Allred D.C. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. The Lancet 2003, 362:361.
-
(2003)
The Lancet
, vol.362
, pp. 361
-
-
Chang, J.C.1
Wooten, E.C.2
Tsimelzon, A.3
Hilsenbeck, S.G.4
Gutierrez, M.C.5
Elledge, R.6
Mohsin, S.7
Osborne, C.K.8
Chamness, G.C.9
Allred, D.C.10
-
7
-
-
66849140730
-
Ki67 Index, HER2 status, and prognosis of patients with luminal B breast cancer
-
Cheang M.C.U., Chia S.K., Voduc D., Gao D., Leung S., Snider J., Watson M., Davies S., Bernard P.S., Parker J.S., Perou C.M., Ellis M.J., Nielsen T.O. Ki67 Index, HER2 status, and prognosis of patients with luminal B breast cancer. JNCI J. Natl. Cancer Inst. 2009, 101:736-750.
-
(2009)
JNCI J. Natl. Cancer Inst.
, vol.101
, pp. 736-750
-
-
Cheang, M.C.U.1
Chia, S.K.2
Voduc, D.3
Gao, D.4
Leung, S.5
Snider, J.6
Watson, M.7
Davies, S.8
Bernard, P.S.9
Parker, J.S.10
Perou, C.M.11
Ellis, M.J.12
Nielsen, T.O.13
-
8
-
-
84865100704
-
A 50-gene intrinsic subtype classifier for prognosis and prediction of benefit from adjuvant tamoxifen
-
Chia S.K., Bramwell V.H., Tu D., Shepherd L.E., Jiang S., Vickery T., Mardis E., Leung S., Ung K., Pritchard K.I., Parker J.S., Bernard P.S., Perou C.M., Ellis M.J., Nielsen T.O. A 50-gene intrinsic subtype classifier for prognosis and prediction of benefit from adjuvant tamoxifen. Clin. Cancer Res. 2012, 18:4465-4472.
-
(2012)
Clin. Cancer Res.
, vol.18
, pp. 4465-4472
-
-
Chia, S.K.1
Bramwell, V.H.2
Tu, D.3
Shepherd, L.E.4
Jiang, S.5
Vickery, T.6
Mardis, E.7
Leung, S.8
Ung, K.9
Pritchard, K.I.10
Parker, J.S.11
Bernard, P.S.12
Perou, C.M.13
Ellis, M.J.14
Nielsen, T.O.15
-
10
-
-
34248595234
-
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients
-
De Azambuja E., Cardoso F., de Castro G., Colozza M., Mano M.S., Durbecq V., Sotiriou C., Larsimont D., Piccart-Gebhart M.J., Paesmans M. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br. J. Cancer 2007, 96:1504-1513.
-
(2007)
Br. J. Cancer
, vol.96
, pp. 1504-1513
-
-
De Azambuja, E.1
Cardoso, F.2
de Castro, G.3
Colozza, M.4
Mano, M.S.5
Durbecq, V.6
Sotiriou, C.7
Larsimont, D.8
Piccart-Gebhart, M.J.9
Paesmans, M.10
-
11
-
-
81555208345
-
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group
-
Dowsett M., Nielsen T.O., A'Hern R., Bartlett J., Coombes R.C., Cuzick J., Ellis M., Henry N.L., Hugh J.C., Lively T., McShane L., Paik S., Penault-Llorca F., Prudkin L., Regan M., Salter J., Sotiriou C., Smith I.E., Viale G., Zujewski J.A., Hayes D.F. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J.Natl. Cancer Inst. 2011, 103:1656-1664.
-
(2011)
J.Natl. Cancer Inst.
, vol.103
, pp. 1656-1664
-
-
Dowsett, M.1
Nielsen, T.O.2
A'Hern, R.3
Bartlett, J.4
Coombes, R.C.5
Cuzick, J.6
Ellis, M.7
Henry, N.L.8
Hugh, J.C.9
Lively, T.10
McShane, L.11
Paik, S.12
Penault-Llorca, F.13
Prudkin, L.14
Regan, M.15
Salter, J.16
Sotiriou, C.17
Smith, I.E.18
Viale, G.19
Zujewski, J.A.20
Hayes, D.F.21
more..
-
12
-
-
84884762173
-
Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy
-
Dowsett M., Sestak I., Lopez-Knowles E., Sidhu K., Dunbier A.K., Cowens J.W., Ferree S., Storhoff J., Schaper C., Cuzick J. Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. J.Clin. Oncol. 2013, 31:2783-2790.
-
(2013)
J.Clin. Oncol.
, vol.31
, pp. 2783-2790
-
-
Dowsett, M.1
Sestak, I.2
Lopez-Knowles, E.3
Sidhu, K.4
Dunbier, A.K.5
Cowens, J.W.6
Ferree, S.7
Storhoff, J.8
Schaper, C.9
Cuzick, J.10
-
13
-
-
84890900735
-
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer
-
Dubsky P., Filipits M., Jakesz R., Rudas M., Singer C.F., Greil R., Dietze O., Luisser I., Klug E., Sedivy R., Bachner M., Mayr D., Schmidt M., Gehrmann M.C., Petry C., Weber K.E., Kronenwett R., Brase J.C., Gnant M. EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer. Ann. Oncol. Mds 2012, 334.
-
(2012)
Ann. Oncol. Mds
, vol.334
-
-
Dubsky, P.1
Filipits, M.2
Jakesz, R.3
Rudas, M.4
Singer, C.F.5
Greil, R.6
Dietze, O.7
Luisser, I.8
Klug, E.9
Sedivy, R.10
Bachner, M.11
Mayr, D.12
Schmidt, M.13
Gehrmann, M.C.14
Petry, C.15
Weber, K.E.16
Kronenwett, R.17
Brase, J.C.18
Gnant, M.19
-
14
-
-
80052845090
-
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors
-
Filipits M., Rudas M., Jakesz R., Dubsky P., Fitzal F., Singer C.F., Dietze O., Greil R., Jelen A., Sevelda P., Freibauer C., Müller V., Jänicke F., Schmidt M., Kölbl H., Rody A., Kaufmann M., Schroth W., Brauch H., Schwab M., Fritz P., Weber K.E., Feder I.S., Hennig G., Kronenwett R., Gehrmann M., Gnant M. A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors. Clin. Cancer Res. 2011, 17:6012-6020.
-
(2011)
Clin. Cancer Res.
, vol.17
, pp. 6012-6020
-
-
Filipits, M.1
Rudas, M.2
Jakesz, R.3
Dubsky, P.4
Fitzal, F.5
Singer, C.F.6
Dietze, O.7
Greil, R.8
Jelen, A.9
Sevelda, P.10
Freibauer, C.11
Müller, V.12
Jänicke, F.13
Schmidt, M.14
Kölbl, H.15
Rody, A.16
Kaufmann, M.17
Schroth, W.18
Brauch, H.19
Schwab, M.20
Fritz, P.21
Weber, K.E.22
Feder, I.S.23
Hennig, G.24
Kronenwett, R.25
Gehrmann, M.26
Gnant, M.27
more..
-
15
-
-
28044472321
-
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer
-
Gianni L., Zambetti M., Clark K., Baker J., Cronin M., Wu J., Mariani G., Rodriguez J., Carcangiu M., Watson D. Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer. J.Clin. Oncol. 2005, 23:7265-7277.
-
(2005)
J.Clin. Oncol.
, vol.23
, pp. 7265-7277
-
-
Gianni, L.1
Zambetti, M.2
Clark, K.3
Baker, J.4
Cronin, M.5
Wu, J.6
Mariani, G.7
Rodriguez, J.8
Carcangiu, M.9
Watson, D.10
-
16
-
-
69449090120
-
Thresholds for therapies: highlights of the st gallen international expert consensus on the primary therapy of early breast cancer 2009
-
Goldhirsch A., Ingle J.N., Gelber R.D., Coates A.S., Thürlimann B., Senn H.-J. Thresholds for therapies: highlights of the st gallen international expert consensus on the primary therapy of early breast cancer 2009. Ann. Oncol. 2009, 20:1319-1329.
-
(2009)
Ann. Oncol.
, vol.20
, pp. 1319-1329
-
-
Goldhirsch, A.1
Ingle, J.N.2
Gelber, R.D.3
Coates, A.S.4
Thürlimann, B.5
Senn, H.-J.6
-
17
-
-
33646874546
-
The molecular portraits of breast tumors are conserved across microarray platforms
-
Hu Z., Fan C., Oh D.S., Marron J.S., He X., Qaqish B.F., Livasy C., Carey L.A., Reynolds E., Dressler L., Nobel A., Parker J., Ewend M.G., Sawyer L.R., Wu J., Liu Y., Nanda R., Tretiakova M., Ruiz Orrico A., Dreher D., Palazzo J.P., Perreard L., Nelson E., Mone M., Hansen H., Mullins M., Quackenbush J.F., Ellis M.J., Olopade O.I., Bernard P.S., Perou C.M. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 2006, 7:96.
-
(2006)
BMC Genomics
, vol.7
, pp. 96
-
-
Hu, Z.1
Fan, C.2
Oh, D.S.3
Marron, J.S.4
He, X.5
Qaqish, B.F.6
Livasy, C.7
Carey, L.A.8
Reynolds, E.9
Dressler, L.10
Nobel, A.11
Parker, J.12
Ewend, M.G.13
Sawyer, L.R.14
Wu, J.15
Liu, Y.16
Nanda, R.17
Tretiakova, M.18
Ruiz Orrico, A.19
Dreher, D.20
Palazzo, J.P.21
Perreard, L.22
Nelson, E.23
Mone, M.24
Hansen, H.25
Mullins, M.26
Quackenbush, J.F.27
Ellis, M.J.28
Olopade, O.I.29
Bernard, P.S.30
Perou, C.M.31
more..
-
18
-
-
84865473325
-
Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma
-
Klimowicz A.C., Bose P., Nakoneshny S.C., Dean M., Huang L., Chandarana S., Magliocco A.M., Wayne Matthews T., Brockton N.T., Dort J.C. Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma. Eur. J. Cancer 2012, 48:2166-2174.
-
(2012)
Eur. J. Cancer
, vol.48
, pp. 2166-2174
-
-
Klimowicz, A.C.1
Bose, P.2
Nakoneshny, S.C.3
Dean, M.4
Huang, L.5
Chandarana, S.6
Magliocco, A.M.7
Wayne Matthews, T.8
Brockton, N.T.9
Dort, J.C.10
-
19
-
-
30944450821
-
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
-
Livasy C.A., Karaca G., Nanda R., Tretiakova M.S., Olopade O.I., Moore D.T., Perou C.M. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod. Pathol. 2006, 19:264-271.
-
(2006)
Mod. Pathol.
, vol.19
, pp. 264-271
-
-
Livasy, C.A.1
Karaca, G.2
Nanda, R.3
Tretiakova, M.S.4
Olopade, O.I.5
Moore, D.T.6
Perou, C.M.7
-
20
-
-
23844534811
-
Reporting recommendations for tumor marker prognostic studies (REMARK)
-
Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics
-
McShane L.M., Altman D.G., Sauerbrei W., Taube S.E., Gion M., Clark G.M. Reporting recommendations for tumor marker prognostic studies (REMARK). J.Natl. Cancer Inst. 2005, 97:1180-1184. Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.
-
(2005)
J.Natl. Cancer Inst.
, vol.97
, pp. 1180-1184
-
-
McShane, L.M.1
Altman, D.G.2
Sauerbrei, W.3
Taube, S.E.4
Gion, M.5
Clark, G.M.6
-
21
-
-
0036840908
-
Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial
-
Mengel M., von Wasielewski R., Wiese B., Rüdiger T., Müller-Hermelink H.K., Kreipe H. Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J.Pathol. 2002, 198:292-299.
-
(2002)
J.Pathol.
, vol.198
, pp. 292-299
-
-
Mengel, M.1
von Wasielewski, R.2
Wiese, B.3
Rüdiger, T.4
Müller-Hermelink, H.K.5
Kreipe, H.6
-
22
-
-
26444546442
-
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
-
Miller L.D., Smeds J., George J., Vega V.B., Vergara L., Ploner A., Pawitan Y., Hall P., Klaar S., Liu E.T., Bergh J. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. PNAS 2005, 102:13550-13555.
-
(2005)
PNAS
, vol.102
, pp. 13550-13555
-
-
Miller, L.D.1
Smeds, J.2
George, J.3
Vega, V.B.4
Vergara, L.5
Ploner, A.6
Pawitan, Y.7
Hall, P.8
Klaar, S.9
Liu, E.T.10
Bergh, J.11
-
23
-
-
33845624887
-
Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR
-
Morey J.S., Ryan J.C., Van Dolah F.M. Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol. Proced. Online 2006, 8:175-193.
-
(2006)
Biol. Proced. Online
, vol.8
, pp. 175-193
-
-
Morey, J.S.1
Ryan, J.C.2
Van Dolah, F.M.3
-
24
-
-
79251480077
-
High genomic grade index associated with poor prognosis for lymph node-negative and estrogen receptor-positive breast cancers and with good response to chemotherapy
-
Naoi Y., Kishi K., Tanei T., Tsunashima R., Tominaga N., Baba Y., Kim S.J., Taguchi T., Tamaki Y., Noguchi S. High genomic grade index associated with poor prognosis for lymph node-negative and estrogen receptor-positive breast cancers and with good response to chemotherapy. Cancer 2011, 117:472-479.
-
(2011)
Cancer
, vol.117
, pp. 472-479
-
-
Naoi, Y.1
Kishi, K.2
Tanei, T.3
Tsunashima, R.4
Tominaga, N.5
Baba, Y.6
Kim, S.J.7
Taguchi, T.8
Tamaki, Y.9
Noguchi, S.10
-
25
-
-
79960841940
-
Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients
-
Naoi Y., Kishi K., Tanei T., Tsunashima R., Tominaga N., Baba Y., Kim S.J., Taguchi T., Tamaki Y., Noguchi S. Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients. Breast Cancer Res. Treat. 2011, 128:633-641.
-
(2011)
Breast Cancer Res. Treat.
, vol.128
, pp. 633-641
-
-
Naoi, Y.1
Kishi, K.2
Tanei, T.3
Tsunashima, R.4
Tominaga, N.5
Baba, Y.6
Kim, S.J.7
Taguchi, T.8
Tamaki, Y.9
Noguchi, S.10
-
26
-
-
84883454353
-
An international Ki67 reproducibility study
-
the International Ki67 in Breast Cancer Working Group of the BIG-NABCG collaboration
-
Nielsen T., Polley M.-Y., Leung S., Mastropasqua M., Zabaglo L., Bartlett J., Viale G., McShane L., Hayes D., Dowsett M. An international Ki67 reproducibility study. Cancer Res. 2012, 72(Suppl. 3). the International Ki67 in Breast Cancer Working Group of the BIG-NABCG collaboration.
-
(2012)
Cancer Res.
, vol.72
, Issue.SUPPL. 3
-
-
Nielsen, T.1
Polley, M.-Y.2
Leung, S.3
Mastropasqua, M.4
Zabaglo, L.5
Bartlett, J.6
Viale, G.7
McShane, L.8
Hayes, D.9
Dowsett, M.10
-
27
-
-
78049453780
-
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer
-
Nielsen T.O., Parker J.S., Leung S., Voduc D., Ebbert M., Vickery T., Davies S.R., Snider J., Stijleman I.J., Reed J., Cheang M.C.U., Mardis E.R., Perou C.M., Bernard P.S., Ellis M.J. A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Clin. Cancer Res. 2010, 16:5222-5232.
-
(2010)
Clin. Cancer Res.
, vol.16
, pp. 5222-5232
-
-
Nielsen, T.O.1
Parker, J.S.2
Leung, S.3
Voduc, D.4
Ebbert, M.5
Vickery, T.6
Davies, S.R.7
Snider, J.8
Stijleman, I.J.9
Reed, J.10
Cheang, M.C.U.11
Mardis, E.R.12
Perou, C.M.13
Bernard, P.S.14
Ellis, M.J.15
-
28
-
-
84864310664
-
Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer
-
Niikura N., Iwamoto T., Masuda S., Kumaki N., Xiaoyan T., Shirane M., Mori K., Tsuda B., Okamura T., Saito Y., Suzuki Y., Tokuda Y. Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer. Cancer Sci. 2012, 103:1508-1512.
-
(2012)
Cancer Sci.
, vol.103
, pp. 1508-1512
-
-
Niikura, N.1
Iwamoto, T.2
Masuda, S.3
Kumaki, N.4
Xiaoyan, T.5
Shirane, M.6
Mori, K.7
Tsuda, B.8
Okamura, T.9
Saito, Y.10
Suzuki, Y.11
Tokuda, Y.12
-
29
-
-
19944422061
-
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast Cancer
-
Paik S., Shak S., Tang G., Kim C., Baker J., Cronin M., Baehner F.L., Walker M.G., Watson D., Park T., Hiller W., Fisher E.R., Wickerham D.L., Bryant J., Wolmark N. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast Cancer. New Engl. J. Med. 2004, 351:2817-2826.
-
(2004)
New Engl. J. Med.
, vol.351
, pp. 2817-2826
-
-
Paik, S.1
Shak, S.2
Tang, G.3
Kim, C.4
Baker, J.5
Cronin, M.6
Baehner, F.L.7
Walker, M.G.8
Watson, D.9
Park, T.10
Hiller, W.11
Fisher, E.R.12
Wickerham, D.L.13
Bryant, J.14
Wolmark, N.15
-
30
-
-
62449131093
-
Supervised risk predictor of breast Cancer based on intrinsic subtypes
-
Parker J.S., Mullins M., Cheang M.C.U., Leung S., Voduc D., Vickery T., Davies S., Fauron C., He X., Hu Z., Quackenbush J.F., Stijleman I.J., Palazzo J., Marron J.S., Nobel A.B., Mardis E., Nielsen T.O., Ellis M.J., Perou C.M., Bernard P.S. Supervised risk predictor of breast Cancer based on intrinsic subtypes. JCO 2009, 27:1160-1167.
-
(2009)
JCO
, vol.27
, pp. 1160-1167
-
-
Parker, J.S.1
Mullins, M.2
Cheang, M.C.U.3
Leung, S.4
Voduc, D.5
Vickery, T.6
Davies, S.7
Fauron, C.8
He, X.9
Hu, Z.10
Quackenbush, J.F.11
Stijleman, I.J.12
Palazzo, J.13
Marron, J.S.14
Nobel, A.B.15
Mardis, E.16
Nielsen, T.O.17
Ellis, M.J.18
Perou, C.M.19
Bernard, P.S.20
more..
-
31
-
-
34447632167
-
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
-
Pawitan Y., Bjöhle J., Amler L., Borg A.-L., Egyhazi S., Hall P., Han X., Holmberg L., Huang F., Klaar S., Liu E.T., Miller L., Nordgren H., Ploner A., Sandelin K., Shaw P.M., Smeds J., Skoog L., Wedrén S., Bergh J. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res. 2005, 7:R953.
-
(2005)
Breast Cancer Res.
, vol.7
-
-
Pawitan, Y.1
Bjöhle, J.2
Amler, L.3
Borg, A.-L.4
Egyhazi, S.5
Hall, P.6
Han, X.7
Holmberg, L.8
Huang, F.9
Klaar, S.10
Liu, E.T.11
Miller, L.12
Nordgren, H.13
Ploner, A.14
Sandelin, K.15
Shaw, P.M.16
Smeds, J.17
Skoog, L.18
Wedrén, S.19
Bergh, J.20
more..
-
32
-
-
0034680102
-
Molecular portraits of human breast tumours
-
Perou C.M., Sørlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A., Fluge O., Pergamenschikov A., Williams C., Zhu S.X., Lønning P.E., Børresen-Dale A.L., Brown P.O., Botstein D. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
-
(2000)
Nature
, vol.406
, pp. 747-752
-
-
Perou, C.M.1
Sørlie, T.2
Eisen, M.B.3
van de Rijn, M.4
Jeffrey, S.S.5
Rees, C.A.6
Pollack, J.R.7
Ross, D.T.8
Johnsen, H.9
Akslen, L.A.10
Fluge, O.11
Pergamenschikov, A.12
Williams, C.13
Zhu, S.X.14
Lønning, P.E.15
Børresen-Dale, A.L.16
Brown, P.O.17
Botstein, D.18
-
33
-
-
84891459472
-
An international Ki67 reproducibility study
-
Polley M.-Y.C., Leung S.C.Y., McShane L.M., Gao D., Hugh J.C., Mastropasqua M.G., Viale G., Zabaglo L.A., Penault-Llorca F., Gown A.M., Symmans W.F., Piper T., Mehl E., Enos R.A., Hayes D.F., Dowsett M., Nielsen T.O. An international Ki67 reproducibility study. JNCI J. Natl. Cancer Inst. Djt 2013, 306.
-
(2013)
JNCI J. Natl. Cancer Inst. Djt
, vol.306
-
-
Polley, M.-Y.C.1
Leung, S.C.Y.2
McShane, L.M.3
Gao, D.4
Hugh, J.C.5
Mastropasqua, M.G.6
Viale, G.7
Zabaglo, L.A.8
Penault-Llorca, F.9
Gown, A.M.10
Symmans, W.F.11
Piper, T.12
Mehl, E.13
Enos, R.A.14
Hayes, D.F.15
Dowsett, M.16
Nielsen, T.O.17
-
34
-
-
84860009382
-
Respective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinoma
-
Reyal F., Bollet M.A., Caly M., Gentien D., Carpentier S., Peyro-Saint-Paul H., Pierga J.-Y., Cottu P., Dieras V., Sigal-Zafrani B., Vincent-Salomon A., Sastre-Garau X. Respective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinoma. PLoS ONE 2012, 7:e35184.
-
(2012)
PLoS ONE
, vol.7
-
-
Reyal, F.1
Bollet, M.A.2
Caly, M.3
Gentien, D.4
Carpentier, S.5
Peyro-Saint-Paul, H.6
Pierga, J.-Y.7
Cottu, P.8
Dieras, V.9
Sigal-Zafrani, B.10
Vincent-Salomon, A.11
Sastre-Garau, X.12
-
35
-
-
0037478605
-
Repeated observation of breast tumor subtypes in independent gene expression data sets
-
Sørlie T., Tibshirani R., Parker J., Hastie T., Marron J.S., Nobel A., Deng S., Johnsen H., Pesich R., Geisler S., Demeter J., Perou C.M., Lønning P.E., Brown P.O., Børresen-Dale A.-L., Botstein D. Repeated observation of breast tumor subtypes in independent gene expression data sets. PNAS 2003, 100:8418-8423.
-
(2003)
PNAS
, vol.100
, pp. 8418-8423
-
-
Sørlie, T.1
Tibshirani, R.2
Parker, J.3
Hastie, T.4
Marron, J.S.5
Nobel, A.6
Deng, S.7
Johnsen, H.8
Pesich, R.9
Geisler, S.10
Demeter, J.11
Perou, C.M.12
Lønning, P.E.13
Brown, P.O.14
Børresen-Dale, A.-L.15
Botstein, D.16
-
36
-
-
60849097255
-
Gene-expression signatures in breast cancer
-
Sotiriou C., Pusztai L. Gene-expression signatures in breast cancer. N.Engl. J. Med. 2009, 360:790-800.
-
(2009)
N.Engl. J. Med.
, vol.360
, pp. 790-800
-
-
Sotiriou, C.1
Pusztai, L.2
-
37
-
-
33144462268
-
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis
-
Sotiriou C., Wirapati P., Loi S., Harris A., Fox S., Smeds J., Nordgren H., Farmer P., Praz V., Haibe-Kains B., Desmedt C., Larsimont D., Cardoso F., Peterse H., Nuyten D., Buyse M., Van de Vijver M.J., Bergh J., Piccart M., Delorenzi M. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J.Natl. Cancer Inst. 2006, 98:262-272.
-
(2006)
J.Natl. Cancer Inst.
, vol.98
, pp. 262-272
-
-
Sotiriou, C.1
Wirapati, P.2
Loi, S.3
Harris, A.4
Fox, S.5
Smeds, J.6
Nordgren, H.7
Farmer, P.8
Praz, V.9
Haibe-Kains, B.10
Desmedt, C.11
Larsimont, D.12
Cardoso, F.13
Peterse, H.14
Nuyten, D.15
Buyse, M.16
Van de Vijver, M.J.17
Bergh, J.18
Piccart, M.19
Delorenzi, M.20
more..
-
38
-
-
48849096940
-
Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients
-
Stuart-Harris R., Caldas C., Pinder S.E., Pharoah P. Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast 2008, 17:323-334.
-
(2008)
Breast
, vol.17
, pp. 323-334
-
-
Stuart-Harris, R.1
Caldas, C.2
Pinder, S.E.3
Pharoah, P.4
-
39
-
-
69749116768
-
Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready?
-
Tang P., Skinner K.A., Hicks D.G. Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready?. Diagn. Mol. Pathol. 2009, 18:125-132.
-
(2009)
Diagn. Mol. Pathol.
, vol.18
, pp. 125-132
-
-
Tang, P.1
Skinner, K.A.2
Hicks, D.G.3
-
40
-
-
84867880533
-
Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information
-
Tobin N.P., Lundgren K.L., Conway C., Anagnostaki L., Costello S., Landberg G. Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information. Hum. Pathol. 2012, 43:2053-2061.
-
(2012)
Hum. Pathol.
, vol.43
, pp. 2053-2061
-
-
Tobin, N.P.1
Lundgren, K.L.2
Conway, C.3
Anagnostaki, L.4
Costello, S.5
Landberg, G.6
-
41
-
-
78650847291
-
Overexpression of human ortholog of mammalian enabled (hMena) is associated with the expression of mutant p53 protein in human breast cancers
-
Toyoda A., Yokota A., Saito T., Kawana H., Higashi M., Suzuki Y., Tanaka T., Kitagawa M., Harigaya K. Overexpression of human ortholog of mammalian enabled (hMena) is associated with the expression of mutant p53 protein in human breast cancers. Int. J. Oncol. 2011, 38:89-96.
-
(2011)
Int. J. Oncol.
, vol.38
, pp. 89-96
-
-
Toyoda, A.1
Yokota, A.2
Saito, T.3
Kawana, H.4
Higashi, M.5
Suzuki, Y.6
Tanaka, T.7
Kitagawa, M.8
Harigaya, K.9
-
42
-
-
18244409687
-
Gene expression profiling predicts clinical outcome of breast cancer
-
Van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A.M., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
-
(2002)
Nature
, vol.415
, pp. 530-536
-
-
Van't Veer, L.J.1
Dai, H.2
van de Vijver, M.J.3
He, Y.D.4
Hart, A.A.M.5
Mao, M.6
Peterse, H.L.7
van der Kooy, K.8
Marton, M.J.9
Witteveen, A.T.10
Schreiber, G.J.11
Kerkhoven, R.M.12
Roberts, C.13
Linsley, P.S.14
Bernards, R.15
Friend, S.H.16
-
43
-
-
0037137519
-
A gene-expression signature as a predictor of survival in breast Cancer
-
Van de Vijver M.J., He Y.D., van't Veer L.J., Dai H., Hart A.A.M., Voskuil D.W., Schreiber G.J., Peterse J.L., Roberts C., Marton M.J., Parrish M., Atsma D., Witteveen A., Glas A., Delahaye L., van der Velde T., Bartelink H., Rodenhuis S., Rutgers E.T., Friend S.H., Bernards R. A gene-expression signature as a predictor of survival in breast Cancer. New Engl. J. Med. 2002, 347:1999-2009.
-
(2002)
New Engl. J. Med.
, vol.347
, pp. 1999-2009
-
-
Van de Vijver, M.J.1
He, Y.D.2
van't Veer, L.J.3
Dai, H.4
Hart, A.A.M.5
Voskuil, D.W.6
Schreiber, G.J.7
Peterse, J.L.8
Roberts, C.9
Marton, M.J.10
Parrish, M.11
Atsma, D.12
Witteveen, A.13
Glas, A.14
Delahaye, L.15
van der Velde, T.16
Bartelink, H.17
Rodenhuis, S.18
Rutgers, E.T.19
Friend, S.H.20
Bernards, R.21
more..
-
44
-
-
84861478152
-
How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists
-
Varga Z., Diebold J., Dommann-Scherrer C., Frick H., Kaup D., Noske A., Obermann E., Ohlschlegel C., Padberg B., Rakozy C., Sancho Oliver S., Schobinger-Clement S., Schreiber-Facklam H., Singer G., Tapia C., Wagner U., Mastropasqua M.G., Viale G., Lehr H.-A. How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists. PLoS ONE 2012, 7:e37379.
-
(2012)
PLoS ONE
, vol.7
-
-
Varga, Z.1
Diebold, J.2
Dommann-Scherrer, C.3
Frick, H.4
Kaup, D.5
Noske, A.6
Obermann, E.7
Ohlschlegel, C.8
Padberg, B.9
Rakozy, C.10
Sancho Oliver, S.11
Schobinger-Clement, S.12
Schreiber-Facklam, H.13
Singer, G.14
Tapia, C.15
Wagner, U.16
Mastropasqua, M.G.17
Viale, G.18
Lehr, H.-A.19
-
45
-
-
84874741005
-
Comparison of EndoPredict and oncotype DX test results in hormone receptor positive invasive breast Cancer
-
Varga Z., Sinn P., Fritzsche F., von Hochstetter A., Noske A., Schraml P., Tausch C., Trojan A., Moch H. Comparison of EndoPredict and oncotype DX test results in hormone receptor positive invasive breast Cancer. PLoS ONE 2013, 8:e58483.
-
(2013)
PLoS ONE
, vol.8
-
-
Varga, Z.1
Sinn, P.2
Fritzsche, F.3
von Hochstetter, A.4
Noske, A.5
Schraml, P.6
Tausch, C.7
Trojan, A.8
Moch, H.9
-
47
-
-
77950308839
-
Breast cancer molecular profiling with single sample predictors: a retrospective analysis
-
Weigelt B., Mackay A., A'hern R., Natrajan R., Tan D.S.P., Dowsett M., Ashworth A., Reis-Filho J.S. Breast cancer molecular profiling with single sample predictors: a retrospective analysis. Lancet Oncol. 2010, 11:339-349.
-
(2010)
Lancet Oncol.
, vol.11
, pp. 339-349
-
-
Weigelt, B.1
Mackay, A.2
A'hern, R.3
Natrajan, R.4
Tan, D.S.P.5
Dowsett, M.6
Ashworth, A.7
Reis-Filho, J.S.8
-
48
-
-
58149330982
-
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
-
Wirapati P., Sotiriou C., Kunkel S., Farmer P., Pradervand S., Haibe-Kains B., Desmedt C., Ignatiadis M., Sengstag T., Schutz F. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res. 2008, 10:R65.
-
(2008)
Breast Cancer Res.
, vol.10
-
-
Wirapati, P.1
Sotiriou, C.2
Kunkel, S.3
Farmer, P.4
Pradervand, S.5
Haibe-Kains, B.6
Desmedt, C.7
Ignatiadis, M.8
Sengstag, T.9
Schutz, F.10
|